Kogure Y - Search Results

1

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.

Fujimoto D, Miura S, Tomii K, Sumikawa H, Yoshimura K, Wakuda K, Oya Y, Yokoyama T, Kijima T, Asao T, Tamiya M, Nakamura A, Yoshioka H, Tokito T, Murakami S, Tamiya A, Yokouchi H, Watanabe S, Yamaguchi O, Morinaga R, Jodai T, Ito K, Shiraishi Y, Kogure Y, Shibaki R, Yamamoto N. Fujimoto D, et al. Among authors: kogure y. Sci Rep. 2023 Mar 6;13(1):3698. doi: 10.1038/s41598-023-30676-y. Sci Rep. 2023. PMID: 36878936 Free PMC article.

2

Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.

Ishii H, Trapnell BC, Tazawa R, Inoue Y, Akira M, Kogure Y, Tomii K, Takada T, Hojo M, Ichiwata T, Goto H, Nakata K; Japanese Center of the Rare Lung Disease Consortium. Ishii H, et al. Among authors: kogure y. Chest. 2009 Nov;136(5):1348-1355. doi: 10.1378/chest.09-0097. Chest. 2009. PMID: 19892674

3

Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.

Kogure Y, Ando M, Saka H, Chiba Y, Yamamoto N, Asami K, Hirashima T, Seto T, Nagase S, Otsuka K, Yanagihara K, Takeda K, Okamoto I, Aoki T, Takayama K, Yamasaki M, Kudoh S, Katakami N, Miyazaki M, Nakagawa K. Kogure Y, et al. J Thorac Oncol. 2013 Jun;8(6):753-8. doi: 10.1097/JTO.0b013e31828b51f5. J Thorac Oncol. 2013. PMID: 23575412 Free article.

4

Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.

Ishii H, Seymour JF, Tazawa R, Inoue Y, Uchida N, Nishida A, Kogure Y, Saraya T, Tomii K, Takada T, Itoh Y, Hojo M, Ichiwata T, Goto H, Nakata K. Ishii H, et al. Among authors: kogure y. BMC Pulm Med. 2014 Mar 5;14:37. doi: 10.1186/1471-2466-14-37. BMC Pulm Med. 2014. PMID: 24597668 Free PMC article.

5

Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study.

Okamoto I, Sakai K, Morita S, Yoshioka H, Kaneda H, Takeda K, Hirashima T, Kogure Y, Kimura T, Takahashi T, Atagi S, Seto T, Sawa T, Yamamoto M, Satouchi M, Okuno M, Nagase S, Takayama K, Tomii K, Maeda T, Oizumi S, Fujii S, Akashi Y, Nishino K, Ebi N, Nakagawa K, Nakanishi Y, Nishio K. Okamoto I, et al. Among authors: kogure y. Oncotarget. 2014 Apr 30;5(8):2293-304. doi: 10.18632/oncotarget.1906. Oncotarget. 2014. PMID: 24810493 Free PMC article. Clinical Trial.

6

Feasibility and accuracy of molecular testing in specimens obtained with small biopsy forceps: comparison with the results of surgical specimens.

Oki M, Yatabe Y, Saka H, Kitagawa C, Kogure Y, Ichihara S, Moritani S. Oki M, et al. Among authors: kogure y. Respiration. 2015;89(3):235-42. doi: 10.1159/000369860. Epub 2015 Feb 11. Respiration. 2015. PMID: 25676841

7

Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations.

Kogure Y, Saka H, Oki M, Saito TI, Ahmed SN, Kitagawa C, Imaizumi K. Kogure Y, et al. PLoS One. 2015 Aug 11;10(8):e0135393. doi: 10.1371/journal.pone.0135393. eCollection 2015. PLoS One. 2015. PMID: 26262682 Free PMC article.

8

Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906.

Kimura T, Taniguchi H, Watanabe N, Saka H, Kogure Y, Shindo J, Ogasawara T, Kojima E, Hasegawa Y, Yamamoto M, Suzuki R, Ando M, Kondo M, Saito H. Kimura T, et al. Among authors: kogure y. Anticancer Res. 2016 Apr;36(4):1767-71. Anticancer Res. 2016. PMID: 27069157 Clinical Trial.

9

[Association between Efficacy of Pemetrexed and EGFR Mutation Status for EGFR Mutated Lung Carcinoma].

Kogure Y, Saka H, Imaizumi K. Kogure Y, et al. Gan To Kagaku Ryoho. 2016 Jun;43(6):733-5. Gan To Kagaku Ryoho. 2016. PMID: 27306810 Japanese.

10

Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.

Seto T, Hirai F, Saka H, Kogure Y, Yoh K, Niho S, Fukase K, Shimada H, Sasai M, Fukino K. Seto T, et al. Among authors: kogure y. Jpn J Clin Oncol. 2018 Jan 1;48(1):31-42. doi: 10.1093/jjco/hyx144. Jpn J Clin Oncol. 2018. PMID: 29136201 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters